本信息仅供教育参考之用,请务必咨询医疗专业人员。 了解更多

New Drug Application

NDA

定义

The formal request submitted to the FDA by a pharmaceutical company to gain approval to market a new drug in the United States. An NDA contains comprehensive data on the drug's chemistry, manufacturing, pharmacology, clinical trials, and proposed labeling. The review process typically takes 10-12 months.

示例

After completing Phase III trials showing efficacy and safety, the manufacturer files an NDA. If approved, the drug can be marketed and prescribed.

相关术语

在指南中提及